{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:30:17Z","timestamp":1787027417271,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mtbio.2026.103422","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:47:12Z","timestamp":1782949632000},"page":"103422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PROTAC-based nanoassemblies targeting BRD4 for potentiate FLASH radiosensitization therapy"],"prefix":"10.1016","volume":"39","author":[{"given":"Ruiling","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinquan","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0843-5491","authenticated-orcid":false,"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103422_bib1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMra1608986","article-title":"Recent developments in radiotherapy","volume":"377","author":"Citrin","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mtbio.2026.103422_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s43018-023-00619-7","article-title":"Harnessing progress in radiotherapy for global cancer control","volume":"4","author":"Jaffray","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mtbio.2026.103422_bib3","article-title":"Biomimetic multifunctional nanoparticles for improved radiotherapy and immunotherapy in cancer treatment","volume":"32","author":"Chen","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2026.103422_bib4","article-title":"Hybrid biomaterials-based radiosensitizers: preparations and their applications in enhancing tumor radiotherapy","volume":"34","author":"Liu","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2026.103422_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.217313","article-title":"Innovative biomaterial strategies for mitigating radiotherapy toxicity: multidimensional mechanistic interventions of nano-microscale materials and hydrogels","volume":"549","author":"Liu","year":"2026","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.mtbio.2026.103422_bib6","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1038\/s41467-023-41782-w","article-title":"Myoglobin-loaded gadolinium nanotexaphyrins for oxygen synergy and imaging-guided radiosensitization therapy","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103422_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41577-021-00568-1","article-title":"Immunomodulation by radiotherapy in tumour control and normal tissue toxicity","volume":"22","author":"Cytlak","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2026.103422_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-019-0064-5","article-title":"Radiotherapy toxicity","volume":"5","author":"De Ruysscher","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.mtbio.2026.103422_bib9","article-title":"The radiotherapy-induced cardiotoxicity in esophagus and stomach cancer","volume":"37","author":"Al\u0131c\u0131ku\u015f","year":"2022","journal-title":"Turk. J. Oncol."},{"key":"10.1016\/j.mtbio.2026.103422_bib10","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0140-6736(17)32072-X","article-title":"Quality of life in patients with cancer in the gaza strip: a cross-sectional study","volume":"390","author":"Shamallakh","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.mtbio.2026.103422_bib11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s43018-025-00905-6","article-title":"FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy","volume":"6","author":"Ni","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mtbio.2026.103422_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.145179","article-title":"AIEgen-based nanotherapeutic strategy for enhanced FLASH irradiation to prevent tumour recurrence and avoid severe side effects","volume":"473","author":"Lyu","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.mtbio.2026.103422_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1078-0432.CCR-17-3375","article-title":"The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients","volume":"25","author":"Vozenin","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103422_bib14","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/mp.15135","article-title":"FLASH radiotherapy with carbon ion beams","volume":"49","author":"Weber","year":"2022","journal-title":"Med. Phys."},{"key":"10.1016\/j.mtbio.2026.103422_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41571-022-00697-z","article-title":"Towards clinical translation of FLASH radiotherapy","volume":"19","author":"Vozenin","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103422_bib16","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1158\/0008-5472.CAN-21-1500","article-title":"FLASH proton radiotherapy spares normal epithelial and mesenchymal tissues while preserving sarcoma response","volume":"81","author":"Velalopoulou","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103422_bib17","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/antiox14111372","article-title":"Factors influencing the biological effects of FLASH irradiation","volume":"14","author":"Glukhov","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.mtbio.2026.103422_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/cells13100835","article-title":"Mechanisms of action in FLASH radiotherapy: a comprehensive review of physicochemical and biological processes on cancerous and normal cells","volume":"13","author":"Chow","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.mtbio.2026.103422_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2022.05.014","article-title":"Pencil beam scanning proton FLASH maintains tumor control while normal tissue damage is reduced in a mouse model","volume":"175","author":"S\u00f8rensen","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.mtbio.2026.103422_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jamaoncol.2022.5843","article-title":"Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: the FAST-01 nonrandomized trial","volume":"9","author":"Mascia","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.mtbio.2026.103422_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103422_bib22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41575-019-0247-2","article-title":"Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers","volume":"17","author":"Buckley","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mtbio.2026.103422_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41467-023-36211-x","article-title":"DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation","volume":"14","author":"Kwon","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103422_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.103422_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41571-022-00709-y","article-title":"Predicting tumour radiosensitivity to deliver precision radiotherapy","volume":"20","author":"Price","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103422_bib26","article-title":"PROTAC prodrug-integrated nanosensitizer for potentiating radiation therapy of cancer","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103422_bib27","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1038\/s41467-022-30787-6","article-title":"BRD4 promotes resection and homology-directed repair of DNA double-strand breaks","volume":"13","author":"Barrows","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103422_bib28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.aat6664","article-title":"BRD4 and MYC\u2014Clarifying regulatory specificity","volume":"360","author":"Sab\u00f2","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2026.103422_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccell.2018.01.019","article-title":"BRD4 inhibition is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency","volume":"33","author":"Sun","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mtbio.2026.103422_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/2159-8290.CD-17-0605","article-title":"BET proteins as targets for anticancer treatment","volume":"8","author":"Stathis","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mtbio.2026.103422_bib31","first-page":"755","article-title":"Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4","volume":"22","author":"Lu","year":"2015","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.mtbio.2026.103422_bib32","doi-asserted-by":"crossref","unstructured":"raina-et-al-2016-protac-induced-bet-protein-degradation-as-a-therapy-for-castration-resistant-prostate-cancer, (n.d.).","DOI":"10.1073\/pnas.1521738113"},{"key":"10.1016\/j.mtbio.2026.103422_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: an emerging drug discovery paradigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2026.103422_bib34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-019-0362-y","article-title":"Development of targeted protein degradation therapeutics","volume":"15","author":"Chamberlain","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.mtbio.2026.103422_bib35","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/s41467-021-23194-w","article-title":"Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103422_bib36","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.scib.2023.04.028","article-title":"Stimuli-activatable PROTACs for precise protein degradation and cancer therapy","volume":"68","author":"Gao","year":"2023","journal-title":"Sci. Bull."},{"key":"10.1016\/j.mtbio.2026.103422_bib37","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2026.103422_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-021-01434-3","article-title":"Proteolysis-targeting chimeras (PROTACs) in cancer therapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2026.103422_bib39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","article-title":"Advancing targeted protein degradation for cancer therapy","volume":"21","author":"Dale","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103422_bib40","article-title":"Glutathione\u2010scavenging nanoparticle\u2010mediated PROTACs delivery for targeted protein degradation and amplified antitumor effects","volume":"10","author":"Liu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mtbio.2026.103422_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1021\/jacs.2c10177","article-title":"Radiotherapy-triggered proteolysis targeting chimera prodrug activation in tumors","volume":"145","author":"Yang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2026.103422_bib42","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","article-title":"Targeted protein degradation: expanding the toolbox","volume":"18","author":"Schapira","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2026.103422_bib43","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1039\/D2CS00220E","article-title":"Chemistries of bifunctional PROTAC degraders","volume":"51","author":"Cao","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2026.103422_bib44","article-title":"Dual targeting of FR+CD44 overexpressing tumors by self-assembled nanoparticles quantitatively conjugating folic acid-hyaluronic acid to the GSH-sensitively modified podophyllotoxin","volume":"505","author":"Zhang","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.mtbio.2026.103422_bib45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41419-019-1564-7","article-title":"Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells","volume":"10","author":"Sui","year":"2019","journal-title":"Cell Death Dis."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426006678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426006678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:58:18Z","timestamp":1787025498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426006678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"alternative-id":["S2590006426006678"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103422","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PROTAC-based nanoassemblies targeting BRD4 for potentiate FLASH radiosensitization therapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103422"}}